G-CSF Cuts Febrile Neutropenia Rates in Early Breast Cancer G-CSF Cuts Febrile Neutropenia Rates in Early Breast Cancer
Women with early-stage breast cancer had a lower rate of febrile neutropenia when given G-CSF alongside their chemotherapy rather than ciprofloxacin.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Cipro | Ciprofloxacin | Health | Hematology | Women